You are here
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Closed on 26 July 2010
Proposed standards and Code of GMP for human blood and blood components, human tissues and human cellular therapies
Closed on 12 February 2010
Second discussion paper: Improving access to Consumer Medicines Information (CMI) and Product Information (PI)
Closed on 30 March 2007
Closed on 27 June 2005